Viewing Study NCT00746434


Ignite Creation Date: 2025-12-25 @ 2:30 AM
Ignite Modification Date: 2025-12-26 @ 1:06 AM
Study NCT ID: NCT00746434
Status: WITHDRAWN
Last Update Posted: 2016-12-05
First Post: 2008-09-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild to Moderate Plaque Psoriasis
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module